Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cerebral artery conditional blood velocity in sickle cell disease: a multicentre study and evidence for active treatment.
Modebe E, Nonyelu C, Duru A, Ezenwosu O, Chukwu B, Madu A, Ezekekwu C, Aneke J, Izuka M, Nri-Ezedi C, Nnachi O, Eze A, Ajuba I, Okwummuo E, Chilaka J, Onodugo C, Fidelis-Ewa U, Agwu O, Anigbogu I, Muoghalu E, Okoye H, Efobi C, Ejiofor O, Ugwu N, Maduka C, Iloanusi N, Ugwu A, Okocha C, Ulasi T, Okpala I. Modebe E, et al. Among authors: okpala i. Arch Dis Child. 2023 Jun;108(6):440-444. doi: 10.1136/archdischild-2022-325106. Epub 2023 Feb 3. Arch Dis Child. 2023. PMID: 36737235
Pilot assessment of omega-3 fatty acids and potassium thiocyanate in sickle cell anemia patients with conditional peak systolic cerebral artery blood velocity.
Ugwu A, Iloanusi N, Ugwu N, Chukwu B, Ezenwosu O, Modebe E, Duru A, Madu A, Chibueze E, Igboke M, Ejiofor O, Efobi C, Uchendu E, Okpala I. Ugwu A, et al. Among authors: okpala i. Blood Cells Mol Dis. 2021 Jul;89:102564. doi: 10.1016/j.bcmd.2021.102564. Epub 2021 Mar 24. Blood Cells Mol Dis. 2021. PMID: 33839465
Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients.
Okoye HC, Ezekekwu C, Nwagha TU, Korubo K, Omunakwe HE, Nnachi OC, Madu AJ, Nwogoh B, Efobi CC, Muoghalu EA, Nonyelu C, Okoye AE, Obodo OI, Ugwu CS, Egolum MC, Nnachi OA, Okpala I. Okoye HC, et al. Among authors: okpala i. Eur J Haematol. 2022 Oct;109(4):321-326. doi: 10.1111/ejh.13811. Epub 2022 Jun 26. Eur J Haematol. 2022. PMID: 35687045
Pilot study of omega-3 fatty acid supplements in sickle cell disease.
Okpala I, Ibegbulam O, Duru A, Ocheni S, Emodi I, Ikefuna A, Umar G, Asinobi I, Madu A, Okoye A, Nwagha T, Oguonu U, Uamai I, Agwu O, Nonyelu C, Anike U, Agu K, Anigbo C, Chukwura A, Ugwu O, Herrada S. Okpala I, et al. APMIS. 2011 Jul;119(7):442-8. doi: 10.1111/j.1600-0463.2011.02751.x. Epub 2011 Apr 17. APMIS. 2011. PMID: 21635551 Clinical Trial.
Addition of multimodal therapy to standard management of steady state sickle cell disease.
Okpala I, Ezenwosu O, Ikefuna A, Duru A, Chukwu B, Madu A, Nwagha T, Ocheni S, Ibegbulam O, Emodi I, Anike U, Nonyelu C, Anigbo C, Agu K, Ajuba I, Chukwura A, Ugwu O, Ololo U. Okpala I, et al. ISRN Hematol. 2013 Dec 9;2013:236374. doi: 10.1155/2013/236374. eCollection 2013. ISRN Hematol. 2013. PMID: 24386573 Free PMC article.
85 results